ARCHIVES

Caution Advised for Hormone Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Race For The Cure Grants For National Capital Area.

June 29, 2001

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993